UROLOGIX INC 4
4 · UROLOGIX INC · Filed Jun 1, 2004
Insider Transaction Report
Form 4
UROLOGIX INCUGX
Doerfert Kirsten
VP Bus/Dev Strategic Plan
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2004-05-28−20,000→ 17,346 totalExercise: $3.88From: 2001-07-05Exp: 2010-07-05→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2004-05-27−2,654→ 37,346 totalExercise: $3.88From: 2001-07-05Exp: 2010-07-05→ Common Stock (2,654 underlying) - Exercise/Conversion
Common Stock
2004-05-27$3.25/sh+7,500$24,375→ 10,147 total - Exercise/Conversion
Common Stock
2004-05-27$4.06/sh+9,846$39,999→ 19,993 total - Exercise/Conversion
Stock Option (right to buy)
2004-05-27−7,500→ 0 totalExercise: $3.25From: 2000-10-26Exp: 2009-10-26→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2004-05-27$3.88/sh+2,654$10,284→ 22,647 total - Exercise/Conversion
Common Stock
2004-05-28$3.88/sh+20,000$77,500→ 22,647 total - Exercise/Conversion
Stock Option (right to buy)
2004-05-27−9,846→ 0 totalExercise: $4.06From: 2001-07-03Exp: 2010-07-03→ Common Stock (9,846 underlying) - Sale
Common Stock
2004-05-27$14.03/sh−20,000$280,576→ 2,647 total - Sale
Common Stock
2004-05-28$14.00/sh−20,000$280,000→ 2,647 total
Footnotes (1)
- [F1]Option vests as to 25% of shares on the anniversary of date of grant with 1/36 of the remaining shares vesting thereafter on each of the nxt 36 monthly anniversaries of the date of grant.